All In Biotech

Drug Trial Radar · NCT06423781

Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)

A Phase 2, Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of BHV-7000 in Treatment of Major Depressive Disorder (MDD)

Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

233

Actual

Start

Aug 1, 2024

Primary completion

Mar 18, 2026

Study completion Mar 18, 2026

Sponsor

Lead sponsor
Biohaven Therapeutics Ltd.Industry
Sponsor type
Industry
First posted
May 21, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000, in participants with Major Depressive Disorder (MDD).

Conditions

  • Major Depressive Disorder

Interventions

  • BHV-7000Drug

    BHV-7000 75 mg taken once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Serious AEs (SAEs), AEs Leading to Study Drug Discontinuation, and AEs judged to be related to study medicationTime frame: Up to 104 weeks
  2. Number of Participants With Clinically Significant Laboratory AbnormalitiesTime frame: Up to 104 weeks
  3. Number of Participants With Vital Sign AbnormalitiesTime frame: Up to 104 weeks
  4. Number of Participants With Electrocardiogram (ECG) Abnormalities specific to QTc elevationTime frame: Up to 104 weeks

Locations

66 sites in 1 country. Site status is shown where the registry gives one.

  • Reverie Mind, LLC

    Chandler, Arizona

  • IMA Clinical Research

    Phoenix, Arizona

  • Pillar Clinical Research, LLC

    Little Rock, Arkansas

  • WIRG

    Little Rock, Arkansas

  • WRN

    Rogers, Arkansas

  • Advanced Research Center, Inc.

    Anaheim, California

  • CIT LA

    Bellflower, California

  • IPMG

    Chino, California

  • WR-PRI Encino

    Encino, California

  • Collaborative Neuroscience Research, LLC (CenExel - CNS)

    Garden Grove, California

  • CalNeuro Research Group

    Los Angeles, California

  • Excell Research, Inc.

    Oceanside, California

  • NRC Research Institute

    Orange, California

  • Anderson Clinical Research

    Redlands, California

  • CIT IE

    Riverside, California

  • Lumos Clinical Research Center, LLC

    San Jose, California

  • Stanford

    Stanford, California

  • Cenexel CNS

    Torrance, California

  • Pacific Clinical Research Management Group

    Upland, California

  • Sunwise Clinical Research

    Walnut Creek, California

  • MCB Clinical Research Centers

    Colorado Springs, Colorado

  • UConn Health

    Farmington, Connecticut

  • Optum Behavioral Care of Connecticut, PC dba Comprehensive Psychiatric Care of Connecticut

    Norwich, Connecticut

  • Clinical Neuroscience Solutions, Inc

    Jacksonville, Florida

  • Floridian Neuroscience Institute

    Miami Lakes, Florida

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida

  • K2 Medical Research

    Tampa, Florida

  • Neuroscience Research Institute

    West Palm Beach, Florida

  • CenExel iResearch, LLC

    Decatur, Georgia

  • CenExel iResearch, LLC

    Savannah, Georgia

  • Uptown Research Institute

    Chicago, Illinois

  • Revive Research Institute, Inc.

    Elgin, Illinois

  • Collective Medical Research

    Overland Park, Kansas

  • DelRicht Research

    New Orleans, Louisiana

  • Headlands Pharmasite

    Baltimore, Maryland

  • CBH Health

    Gaithersburg, Maryland

  • Copley Clinical

    Boston, Massachusetts

  • Boston Clinical Trials

    Boston, Massachusetts

  • Adams Clinical

    Watertown, Massachusetts

  • Precise Clinical Research

    Flowood, Mississippi

Showing 40 of 66 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.